Anzeige
Mehr »
Mittwoch, 17.09.2025 - Börsentäglich über 12.000 News
Die Ethereum-Vorreiter: Wie Republic Technologies die Infrastruktur der Zukunft aufbaut
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FierceBiotech

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
20.08.After a 'complete standstill,' private biotech market reaches new normal, investor says
20.08.Rocket launches from FDA hold, but uncertainty about the biotech's cash runway looms
20.08.Xoma adds fading Mural Oncology to portfolio of struggling biotechs
20.08.Jazz pays Saniona $42.5M to add preclinical prospect to epilepsy ensemble
20.08.Celldex ends esophageal program despite hitting primary endpoint in phase 2 trial
19.08.FDA rejection derails PTC Therapeutics' rare disease hopeful
19.08.FDA pushes back PDUFA date for Regenxbio's Hunter syndrome gene therapy
19.08.Viking hits stormy seas as phase 2 oral obesity data sink stock
19.08.VantAI plays matchmaker for Halda's 'hold-and-kill' drugs in $1B deal
19.08.Opthea, still reeling from eye disease flops, ramps up cuts to 85% of staff and loses CEO
19.08.China's RemeGen sells Asia rights to VEGF/FGF eye drug in $180M deal
19.08.CSL to lay off up to 15% of workforce, cut R&D costs and spin out vaccine unit
18.08.Shankar Ramaswamy's gene therapy biotech raises $313M
18.08.Genentech scraps $2B deal with cell therapy biotech
18.08.Stealth Bio submits third FDA application for rare disease candidate
18.08.Neurizon becomes second biotech hit with FDA delay for ALS candidate
18.08.Boehringer pens $327M pact with Palatin to develop new therapies for diabetic retinopathy
18.08.Merck KGaA swoops into Skyhawk neurological disease pact worth up to $2B
18.08.Reunion's psychedelic prodrug reduces postpartum depression symptoms in phase 2 study
18.08.Pfizer's SCD drug fails phase 3 study in latest blow to Global Blood Therapeutics' legacy
15.08.FDA delays Omeros' 2nd attempt at transplant drug's approval by 3 months
14.08.Evotec's reorg claims 600 jobs, hundreds more than originally planned
14.08.Cancer biotech Prelude calls it curtains on lead SMARCA2 degrader
14.08.Superluminal secures $1.3B pact with backer Lilly to develop cardiometabolic, obesity drugs
14.08.Schrödinger abandons CDC7 inhibitor after therapy is linked to 2 patient deaths